HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation.

Abstract
CXCR4 is a major receptor for CXCL12 and is known to participate in multiple physiological systems. The present study tested a second generation CXCR4 antagonist, AMD3465, for effects on highly defined models of Th1- and Th2-cell-mediated hypersensitivity-type pulmonary granuloma formation. Type-1 and type-2 granulomas were induced, respectively, by intravenous challenge of sensitized CBA/J mice with Mycobacteria bovis purified protein derivative- or Schistosoma mansoni egg antigen-coated beads. Before challenge, mice were implanted with osmotic pumps releasing AMD3465 at 5 microg/hour (6 mg/kg/day). Compared to vehicle, AMD3465 had minimal effect on type-1 inflammation or cytokine responses in draining lymph nodes, but the type-2 inflammation was significantly abrogated with reductions in lesion size and eosinophil content as well as abrogated interleukin (IL)-5, IL-10, and IL-13 cytokine production in draining lymph nodes. The biased effect of AMD3465 correlated with greater CXCR4 ligand expression in the type-2 model. Treatment during a primary response impaired lymph node IL-2 production after both Mycobacteria bovis purified protein derivative and Schistosoma mansoni egg antigen challenge indicating an unbiased effect during immune induction. In summary, CXCR4 blockade inhibited eosinophil recruitment during type-2 granuloma formation and interfered with primary and secondary T-cell activation events in lymphoid tissue, suggesting potential therapeutic application for chronic hypersensitivity diseases.
AuthorsJerry S Hu, Christine M Freeman, Valerie R Stolberg, Bo Chin Chiu, Gary J Bridger, Simon P Fricker, Nicholas W Lukacs, Stephen W Chensue
JournalThe American journal of pathology (Am J Pathol) Vol. 169 Issue 2 Pg. 424-32 (Aug 2006) ISSN: 0002-9440 [Print] United States
PMID16877345 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Antigens, Helminth
  • Chemokine CXCL12
  • Chemokines, CXC
  • Cxcl12 protein, mouse
  • Cytokines
  • Interleukin-2
  • N-(1,4,8,11- tetraazacyclotetradecanyl-1,4-phenylenebis(methylene))-2-(aminomethyl)- pyridine
  • Pyridines
  • RNA, Messenger
  • Receptors, CXCR4
Topics
  • Animals
  • Antigens, Helminth (immunology)
  • Cells, Cultured
  • Chemokine CXCL12
  • Chemokines, CXC (genetics)
  • Cytokines (biosynthesis)
  • Dose-Response Relationship, Drug
  • Eosinophils (immunology)
  • Female
  • Gene Expression Regulation (drug effects)
  • Granuloma, Respiratory Tract (chemically induced, pathology)
  • Interleukin-2 (biosynthesis)
  • Lung (drug effects, pathology)
  • Lymph Nodes (drug effects)
  • Mice
  • Pyridines (pharmacology)
  • RNA, Messenger (genetics, metabolism)
  • Receptors, CXCR4 (antagonists & inhibitors, genetics)
  • Schistosoma mansoni (immunology)
  • Th2 Cells (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: